Acute Deep Vein Thrombosis

The commercial driver is at increased risk for developing acute deep vein thrombosis (DVT) due to long hours of sitting as required by the profession. DVT can be the source of pulmonary emboli that can cause sudden incapacitation or death. Adequate treatment with anticoagulants decreases the risk of recurrent thrombosis by approximately 80%.

Waiting period

No recommended time frame

You should not certify the driver until etiology is confirmed and treatment has been shown to be adequate/effective, safe, and stable.

Decision

Maximum certification period — 1 year

Recommend to certify if:

The driver has no residual acute DVT.

Recommend not to certify if:

The driver has DVT until effectively treated.

Monitoring/Testing

When DVT treatment includes anticoagulant therapy, the driver should meet monitoring guidelines.

Follow-up

The driver should have an annual medical examination.

Venous Disease Recommendation Table (PDF)